本文選題：宮頸腫瘤 + TCT檢測��； 參考：《臨床合理用藥雜志》2016年36期

【摘要】：目的探討薄層液基細(xì)胞學(xué)檢測技術(shù)(TCT)、HPV-DNA分型聯(lián)合陰道鏡在宮頸癌篩選中的應(yīng)用價(jià)值。方法選取2014—2015年于靈丘縣婦幼保健院行宮頸檢查并診斷為宮頸病變的患者927例,均行TCT檢測、HPV-DNA分型檢測,并對(duì)859例高度懷疑為宮頸癌患者在陰道鏡下進(jìn)行宮頸活組織檢測、TCT檢測、HPV-DNA分型檢測及病理檢測,對(duì)比分析其檢查結(jié)果。結(jié)果 TCT檢測為正常或炎癥患者HPV-DNA分型檢測的陽性率低于TCT檢測為低度鱗狀上皮內(nèi)病變及高度鱗狀上皮內(nèi)病變(P0.05);TCT檢測為非典型鱗狀上皮細(xì)胞病變患者HPVDNA分型檢測的陽性率低于TCT檢測為高度鱗狀上皮內(nèi)病變及鱗狀細(xì)胞癌(P0.05)。TCT、HP-DNA分型檢測對(duì)病理學(xué)檢測結(jié)果為重度不典型增生及鱗狀細(xì)胞癌患者的陽性檢出率高于輕度、中度不典型增生(P0.05)。TCT、HPV-DNA及陰道鏡聯(lián)合對(duì)輕、中、中度不典型增生的準(zhǔn)確率高于TCT與HPV-DNA聯(lián)合(P0.05)。結(jié)論 TCT、HPV-DNA分型聯(lián)合陰道鏡在宮頸癌篩選中安全、高效,可降低漏診率。
[Abstract]:Objective to investigate the application value of TCTL HPV-DNA typing combined with colposcopy in screening cervical cancer. Methods from 2014 to 2015, 927 cases of cervical diseases were examined and diagnosed in Lingqiu County Maternal and Child Health Care Hospital. All of them were detected by TCT and HPV-DNA typing. HPV-DNA typing and pathological examination were performed in 859 highly suspected cervical cancer patients under colposcopy. The results were compared and analyzed. Results the positive rate of HPV-DNA typing in normal or inflammatory patients with TCT was lower than that in patients with low grade squamous intraepithelial lesions (LSCI) and high squamous intraepithelial lesions (HPVDNA). The positive rate of HP-DNA was lower than that of TCT in patients with high squamous intraepithelial lesions and squamous cell carcinoma. The positive rate of HP-DNA typing in patients with severe atypical hyperplasia and squamous cell carcinoma was higher than that in mild squamous cell carcinoma. The accuracy of HPV-DNA combined with colposcopy for mild and moderate dysplasia was higher than that of TCT combined with HPV-DNA. Conclusion TCTN HPV-DNA typing combined with colposcopy is safe and effective in screening cervical cancer and can reduce the rate of missed diagnosis.
【作者單位】： 山西省靈丘縣婦幼保健院;
【分類號(hào)】：R737.33

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 王雪云,陳文,李卓華,黃遠(yuǎn)征;陰道鏡檢查配合HPV-DNA檢測診斷宮頸病變的意義(綜述)[J];廣州醫(yī)藥;2004年02期

2 梅冰,朱俊真,郝玉賓,楚偉,李亞麗;泌尿生殖道感染HPV-DNA檢測的優(yōu)生意義[J];中國優(yōu)生與遺傳雜志;2000年S1期

3 唐禮榕;張志毅;;HPV-DNA檢測在宮頸病變診斷中的價(jià)值[J];中國癌癥雜志;2006年03期

4 高宗俠;凌斌;周穎;吳大保;肖敏;程志祥;高婷;沈國棟;;熒光定量PCR檢測宮頸癌旁盆腔組織中HPV-DNA的臨床意義[J];實(shí)用癌癥雜志;2007年04期

5 邱銳;婁閣;;TCT和HPV-DNA檢測聯(lián)合陰道鏡對(duì)宮頸癌篩查的應(yīng)用價(jià)值[J];海南醫(yī)學(xué)院學(xué)報(bào);2014年06期

6 佟銳;王純雁;;HPV-DNA、TCT聯(lián)合檢測在宮頸癌中的診斷價(jià)值[J];中國實(shí)驗(yàn)診斷學(xué);2014年04期

7 黎卓華;黎文杰;;HPV-DNA檢測與子宮頸癌[J];國際檢驗(yàn)醫(yī)學(xué)雜志;2009年03期

8 趙志新;劉建;金志榮;周鳳林;薩仁娜;徐海霞;;蒙古族患者子宮頸TCT異常病例與HPV-DNA及病理組織學(xué)診斷結(jié)果的比較分析[J];中國實(shí)用醫(yī)藥;2012年24期

9 孫曉莉;高美華;王在秋;楊建華;于麗梅;;HPV-DNA與TCT聯(lián)合檢測在宮頸癌診斷中的應(yīng)用[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2012年09期

10 王紅;李晴;金玲;汪艷珠;;對(duì)ASC-US病例進(jìn)行HPV-DNA檢測的分層篩查的臨床價(jià)值[J];中國腫瘤;2012年08期

，

本文編號(hào)：2036340